iCAD, Inc. (NASDAQ:ICAD) Sees Significant Increase in Short Interest

iCAD, Inc. (NASDAQ:ICAD) was the recipient of a large growth in short interest during the month of October. As of October 15th, there was short interest totalling 235,600 shares, a growth of 8.7% from the September 30th total of 216,700 shares. Approximately 0.9% of the company’s shares are sold short. Based on an average daily trading volume, of 157,300 shares, the short-interest ratio is currently 1.5 days.

Analyst Ratings Changes

Separately, StockNews.com upgraded shares of iCAD from a “sell” rating to a “hold” rating in a report on Thursday, August 22nd.

iCAD Trading Down 2.6 %

ICAD stock traded down $0.05 during midday trading on Wednesday, hitting $1.85. The stock had a trading volume of 65,838 shares, compared to its average volume of 164,277. The firm has a market cap of $49.10 million, a P/E ratio of -15.83 and a beta of 1.50. The business has a fifty day moving average price of $1.62 and a two-hundred day moving average price of $1.50. iCAD has a 1-year low of $1.18 and a 1-year high of $2.65.

iCAD (NASDAQ:ICAD) last announced its earnings results on Tuesday, August 13th. The technology company reported ($0.07) EPS for the quarter. iCAD had a negative net margin of 15.67% and a negative return on equity of 13.59%. The business had revenue of $5.03 million for the quarter.

Institutional Trading of iCAD

Several hedge funds have recently modified their holdings of the stock. Virtu Financial LLC raised its stake in iCAD by 55.6% during the 1st quarter. Virtu Financial LLC now owns 21,286 shares of the technology company’s stock worth $34,000 after buying an additional 7,604 shares during the period. AMH Equity Ltd bought a new stake in shares of iCAD during the first quarter valued at approximately $207,000. Perritt Capital Management Inc raised its position in shares of iCAD by 14.2% during the second quarter. Perritt Capital Management Inc now owns 159,900 shares of the technology company’s stock worth $208,000 after purchasing an additional 19,917 shares during the period. Essex LLC acquired a new position in shares of iCAD during the third quarter worth approximately $216,000. Finally, Perritt Capital Management Inc. lifted its holdings in shares of iCAD by 7.5% in the 1st quarter. Perritt Capital Management Inc. now owns 139,983 shares of the technology company’s stock worth $225,000 after purchasing an additional 9,717 shares in the last quarter. Institutional investors own 24.61% of the company’s stock.

About iCAD

iCAD, Inc engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis.